News Releases

Alcresta to Present at the 34th Annual J.P. Morgan Healthcare Conference

Jan 06, 2016

Corporate presentation at J.P. Morgan Healthcare Conference

Alcresta Receives FDA Clearance for RELiZORB™

Dec 02, 2015

First Digestive Enzyme Cartridge Designed for Patients on Enteral Feeding

Alcresta to Present at 29th Annual North American Cystic Fibrosis Conference

Oct 08, 2015

Expands Leadership Team in Preparation for Commercial Launch

Alcresta Presents New Data at 28th Annual North American Cystic Fibrosis Conference (NACFC)

Oct 23, 2014

Demonstrating Potential of Proprietary Enzyme-Based Technology to Improve Nutrition in Patients with Exocrine Pancreatic Insufficiency

Alcresta Announces Agreement with Cystic Fibrosis Foundation Therapeutics

Apr 17, 2014

Agreement Highlights Importance of Medical Nutrition in Managing Cystic Fibrosis

Alcresta Launches Innovative Enzyme-Based Nutritional Company

Apr 17, 2012

Proprietary Platform for Nutritional Products that Improve Health and Manage Disease; Founded with New Synergistic Business Model by Proven Team and Top-Tier VCs